Skip to content
Search

Latest Stories

UK says no decision on payment for positive Covid-19 tests

THE British government has taken no decision on whether to pay £500 ($683) to everyone in England who tests positive for Covid-19, environment minister George Eustice said.

Newspapers cited a policy paper which they said showed the government was considering such a move to encourage more people to take tests for the new coronavirus though it would cost £453 million a week.


Studies show many people ignore instructions to self-isolate when they have contact with someone who has the virus because of the financial impact of being unable to work while quarantining for 10 days.

Some low-paid people already receive a £500 payment if they self-isolate. The newspaper reports said the government was considering a universal payment.

"I'm not going to comment on this particular paper but we've always kept it under review," Eustice said. "No decisions to be made on this, but this is a dynamic, fast-moving situation with the pandemic."

Eustice said the government recognised that self-isolating was "a financial challenge for some."

Cases surged in Britain at the end of last year, fuelled by a new highly transmissible strain of the virus which has put the health service under extreme pressure. On Thursday(21), Britain recorded 37,892 new cases with 1,290 deaths.

Lockdowns are in place across the UK to try to curb the spread of the virus, but a prevalence survey suggested infections had not fallen in the first days of the new lockdown introduced in England on Jan. 5.

The government has warned people who break rules they will face punishment by police.

Prime minister Boris Johnson said on Thursday it was too early to say when restrictions could be lifted, but hopes a mass vaccination programme will pave a way for a return to some degree of normality by the spring.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less